Clinical Trial Update: SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 SAD/MAD and food-effect study of SAP-001 tablets in Chinese subjects has completed. Sponsor: Shanton Pharma Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• SAP-001

Snippet

Sponsor: Shanton Pharma Co., Ltd. | Conditions: Gout, Hyperuricemia | Phase 1 | Status: COMPLETED